Search for: "PFIZER INC" Results 1181 - 1200 of 1,505
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Aug 2012, 5:00 am by Bexis
Pfizer (femoral stem) Deposition1998-06-30 Suerth v. [read post]
5 Jan 2008, 6:00 am
Navy: (IP Law360),Crown Packaging - Summary judgment granted to Reexam Beverage Co finding patent infringement by Crown: (Delaware IP Law),eBay - District Court held that likelihood of confusion analysis is not limited to the goods or services for which mark was registered in Applied Information Sciences v eBay: (IP Law Observer),Global Patent Holdings - GPH files another patent infringement case regarding their JPEG on a website patent: (Troll … [read post]
6 Feb 2009, 8:19 am
Opinion below (Federal Circuit) Petition for certiorari Brief in opposition Petitioner's reply Brief amicus curiae of the Washington Legal Foundation (in support of petitioner) Brief amicus curiae of Pfizer, Inc. [read post]
2 Oct 2008, 12:36 pm
Danek Medical, Inc., 1999 WL 1054864, *6 (M.D. [read post]
12 May 2015, 3:26 pm by James Galvin
The following is a list of some of the UBS Reverse Convertible Notes offered: CUSIP Issuer Product Name 90261J426 UBS Yield Optimization Notes with Contingent Protection linked to Starbucks Corp. 90261J434 UBS Yield Optimization Notes with Contingent Protection linked to Intel Corp. 90261J459 UBS Yield Optimization Notes with Contingent Protection linked to Apple, Inc. 90261J319 UBS Yield Optimization Notes with Contingent Protection linked linked to Occidental Petroleum Corp.… [read post]
17 Mar 2020, 1:32 pm by Noble McIntyre
Twelve Lots of CHANTIX® (Varenicline) Tablets have been recalled by Pfizer due to N-Nitroso Varenicline content above ADI level. [read post]
2 Dec 2011, 2:00 pm by Bexis
Pfizer Pharmaceutical Co., 2011 WL 3157305, at *3 (D. [read post]
17 Jun 2012, 3:52 pm by Stephen Jenei
Prior to founding RaymondStevenson in 2007, Betsy worked with Pfizer Inc’s Corporate Communications group, where she developed strategy and directed international and top-tier media relations for the company’s Oncology and Central Nervous System portfolios and served as media counsel for Pfizer’s Chief Medical Officer and Senior Vice President Worldwide Development. [read post]
30 Sep 2010, 5:58 am by David G. Badertscher
The petitioners have asked the SEC to stay the Nov. 15 effective date of the rules pending conclusion of the litigation.Chief Justice to Hear Pfizer Cases After Selling Company's StockThe Associated PressChief Justice John Roberts has sold his shares of Pfizer Inc., a move that allows him to participate in two pending Supreme Court cases involving the pharmaceutical maker. [read post]
30 Oct 2009, 6:04 am
Axcelis Technologies, Inc., decided September 29, 2009 - involved something of a collateral issue: namely, whether to permit inspection of documents relating to the board's decision to reject the proffered resignations of three directors. [read post]